4
Changes in Ownership
Cabaletta Bio, Inc. Filed Acc 0000899243-21-009235
Options or other derivatives
- Chief Medical Officer acquired 113,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chang David J. Chief Medical Officer | 2021-03-01 | Grant or award · Stock Option (Right to Buy) | +113,500 | 113,500 | D | ||
Loading xslF345X03/doc4.xml…